Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation
American Journal of Transplantation, 05/17/2012Riella LV et al.
Statins are considered the agents of choice, though their use may be complicated by drug misadventures. Pravastatin, fluvastatin and pitavastatin are considered to be the safest statins to use in this population; however, given their low–potency, a high–potency statin, such as atorvastatin, may be necessary in patients with significant dyslipidemia.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.